ADC Therapeutics ADCT
NYSE ADCT
$1.60 +0.09 (+5.96%)
At close: Nov 11, 2026 · 4:00 PM EST

ADC Therapeutics (ADCT) Return on Equity [ROE] (2020 - 2023)

Updated

ADC Therapeutics' Return on Equity [ROE] was -4155.58% in Q2 2023, down 4021.08 percentage points from -134.50% a year earlier and down 3787.44 percentage points from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Return on Equity [ROE] (2020 - 2023) Analysis & Trends

For FY2022, Return on Equity [ROE] at ADC Therapeutics came in at -133.46%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 ADC Therapeutics 192.88 Mn -707.77 Mn 19.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -4,155.58%
Mar 31, 2023 -368.15%
Dec 31, 2022 -169.13%
Sep 30, 2022 -150.84%
Jun 30, 2022 -134.50%
Mar 31, 2022 -123.25%
Dec 31, 2021 -134.78%
Sep 30, 2021 -116.68%
Jun 30, 2021 -73.95%
Mar 31, 2021 -80.30%
Dec 31, 2020 -69.22%
Sep 30, 2020 -78.85%
Jun 30, 2020 -176.90%
Mar 31, 2020 -146.31%
API Access

ADC Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEY